Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

First US implant for IntraTherapeutics iliac stent:

This article was originally published in Clinica

Executive Summary

IntraTherapeutics has reported that the first human implant of its iliac stent for revascularising the main artery supplying blood to the legs has been performed successfully as part of the company's US trial for the device. The second generation, stainless-steel, balloon-expandable stent has improved flexibility, radial strength and coverage, according to the company. Studies have shown that stenting the iliac effectively treats claudication, or leg pain in patients with peripheral vascular disease, said St Paul, Minnesota-based IntraTherapeutics.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT079351

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel